Evidence map›Paper›PMID 38116541›Full record

ArticleCase reports in endocrinology2023

Thymic Carcinoid in a Patient with Concurrent Manifestations of Multiple Endocrine Neoplasia Type 1.

Jasmine Zhu, Samantha Dean, Umbreen Hafeez, Sandra Neoh

Abstract readCase Reports
In one paragraph

Article in Case reports in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jasmine ZhuDepartment of Endocrinology, Austin Health, 145 Studley Rd, Heidelberg, VIC 3084, Australia.ORCID https://orcid.org/0000-0003-2309-5156
Samantha DeanDepartment of Oncology, Austin Health, 145 Studley Rd, Heidelberg, VIC 3084, Australia.ORCID https://orcid.org/0000-0001-8183-4119
Umbreen HafeezMelbourne Medical School, University of Melbourne, Parkville, VIC 3010, Australia.ORCID https://orcid.org/0000-0001-7963-6367
Sandra NeohDepartment of Endocrinology, Austin Health, 145 Studley Rd, Heidelberg, VIC 3084, Australia.ORCID https://orcid.org/0000-0001-9387-7079

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thymic carcinoid tumours, especially in the context of multiple endocrine neoplasia type 1 (MEN 1), present significant clinical challenges due to their rarity and aggressive nature. This case report describes a complex patient with MEN 1, who suffered from multiple manifestations of the disease, including thymic carcinoid. The tumour was initially resected and treated with adjuvant radiotherapy. Due to slow progression over the years, the tumour was treated with two lines of chemotherapy before the patient succumbed to progressive disease. There is currently limited evidence favoring any specific medical treatment for thymic carcinoid.

Identifiers

PMID38116541
PMCPMC10728356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.